China Botanic Pharmaceutical Inc., of Harbin, China, said that on March 1, the company received notice from the staff of the New York Stock Exchange that the plan of compliance previously submitted to the exchange had been accepted with a compliance date of May 1
TA = Tel Aviv Stock Exchange. @ This column reflects the shares outstanding following the offering, when disclosed. % Market capitalization is calculated based on the offering price
Ablynx NV, of Ghent, Belgium, and Spirogen Ltd., of London, inked a research collaboration to evaluate the potential of a cancer drug conjugate combining Spirogen's cytotoxic drugs, pyrrolobenzodiazepines and associated linker technology, with Nanobodies generated using Ablynx's technology platform. Under the terms, Ablynx will provide access to Nanobodies against an undisclosed target, and Spirogen will provide access to its cytotoxic warheads and conjugation technologies. The collaboration
BioWorld International | Wednesday, February 27, 2013
The best outcome may be a reverse merger by a private company seeking to utilize Phytopharm's cash, London Stock Exchange listing and accumulated tax losses." – Robin Davison, analyst, Edison Investment Research on Phytopharm's failure of it lead program in Parkinson's disease "Most companies that have delivery technology
stock exchanges (NASDAQ, NYSE or AMEX) from Jan. 1 - Dec. 31, 2012. # After-market performance is expressed as the percent change in stock price between the offering price and the closing price on 12/31/12
stock exchanges (NASDAQ, NYSE or AMEX) from Jan. 1 - Dec. 31, 2012. # After-market performance is expressed as the percent change in stock price between the offering price and the closing price on 12/31/12
stock exchanges (NASDAQ, NYSE or AMEX) from Jan. 1 - Dec. 31, 2012. # After-market performance is expressed as the percent change in stock price between the offering price and the closing price on 12/31/12
stock exchanges (NASDAQ, NYSE or AMEX) from Jan. 1 - Dec. 31, 2012. # After-market performance is expressed as the percent change in stock price between the offering price and the closing price on 12/31/12
China Botanic Pharmaceutical Inc., of Harbin, China, said that on March 1, the company received notice from the staff of the New York Stock Exchange that the plan of compliance previously submitted to the exchange had been accepted with a compliance date of May 1